COMMUNIQUÉS West-GlobeNewswire

Oraticx Expands Oral Probiotics Lineup for Daily Oral Care and Oral Microbiome Wellness
02/06/2026
New product range introduces targeted probiotic oral care solutions for everyday wellness routines Oraticx Logo LOS ANGELES, June 02, 2026 (GLOBE NEWSWIRE) -- Oraticx, a wellness brand focused on oral microbiome balance [...]
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
02/06/2026
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
02/06/2026
CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
02/06/2026
IRVING, Texas, June 02, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is proud to announce its continued support of the OMS Foundation with a gift-match incentive for the Foundation’s mid-year [...]
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
02/06/2026
Defense-industry veteran brings experience developing imaging, sensing, and intelligence systems for aerospace, defense, and homeland security NETANYA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American [...]
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
02/06/2026
Promising Phase 1 data for LB2501, a potential first ‑ in ‑ class CD19/CD20 dual ‑ targeting in vivo CAR-T therapy, as an off-the-shelf, single-infusion treatment for B ‑ cell malignancies An ORR of 100% (6/6) was [...]
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
02/06/2026
- The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program - - 30 mg onvansertib + FOLFIRI/bevacizumab arm showed a [...]
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa as chief technology [...]
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
02/06/2026
MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA (TSX-V: PHA) ( “Premier Health” , or the “Company” ) announces that the Company’s unaudited interim financial statements and the related management’s [...]
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling. The [...]
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
02/06/2026
ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas [...]
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
02/06/2026
XPro1595 showed a highly significant treatment effect in the full mITT population (p=0.0028; d=0.46; n=200), demonstrating broad tissue-level target engagement and treatment-related biological effect. Efficacy was [...]
Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report
02/06/2026
Fifth annual report introduces refreshed impact strategy, aligned with long-term, responsible growth ORANGE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today issued its 2025 [...]
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD
02/06/2026
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y, June 02, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company [...]
Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance
02/06/2026
ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today [...]
Tris Pharma Announces Presentation on The Complexity and Management of ADHD at Psych Congress Elevate 2026
02/06/2026
Presentation by leading expert Andrew J. Cutler, MD, will examine the lifelong impact of ADHD, risks of leaving the condition untreated, and importance of individualized treatment Presentation will also feature [...]
Palvella Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
02/06/2026
WAYNE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies [...]
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
02/06/2026
PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will [...]
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
02/06/2026
Optimi’s 5mg psilocybin capsules are prescribed commercially for treatment-resistant depression in Australia, with additional product from the run earmarked for planned clinical trials in the United States and Europe [...]

Pages